ERIKA MURTHA: Open Payments
NPI 1619326972 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 64 payments from 14 companies in 2025. Trend: 2023 $115 · 2024 $267 · 2025 $1,023
Food & beverage: $978Education: $45
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 33 | $207 |
| AstraZeneca Pharmaceuticals LP | 6 | $176 |
| Insmed, Inc. | 5 | $119 |
| Pulmonx Corporation | 4 | $105 |
| Inspire Medical Systems, Inc. | 1 | $105 |
| GENZYME CORPORATION | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Grifols USA, LLC | 2 | $35 |
| JAZZ PHARMACEUTICALS INC. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
Products named: DUPIXENT, NUCALA, CHARTIS CATHETER, INSPIRE, TRELEGY ELLIPTA, BREZTRI, AIRSUPRA, Arikayce.
Industry payments across MI — which companies pay providers there.
